0001071739-14-000139.txt : 20141212 0001071739-14-000139.hdr.sgml : 20141212 20141211183254 ACCESSION NUMBER: 0001071739-14-000139 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20141212 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20141212 DATE AS OF CHANGE: 20141211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 141281816 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 form8-k.htm FORM 8-K 2014.12.12 Form 8-K



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 12, 2014

CENTENE CORPORATION
(Exact Name of Registrant as Specified in Charter)

Delaware
 
001-31826
 
42-1406317
(State or Other Jurisdiction
of Incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)

7700 Forsyth Blvd.
St. Louis, Missouri
 
63105
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (314) 725-4477
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






ITEM 7.01 REGULATION FD DISCLOSURE
On December 12, 2014, the Company issued a press release announcing its 2015 financial guidance and confirming its 2014 financial guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the website cited in the press release is not a part of this report.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits.
99.1 Press release of Centene Corporation issued December 12, 2014.





SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
CENTENE CORPORATION
 
 
 
 
 
Date:
December 12, 2014
By:
 
/s/ William N. Scheffel
 
 
 
 
William N. Scheffel
Executive Vice President & Chief Financial Officer




EXHIBIT INDEX
Exhibit Number
 
Description
99.1
 
Press release of Centene Corporation issued December 12, 2014.




EX-99.1 2 exhibit991.htm PRESS RELEASE 2014.12.12 8-K Exhibit 99.1 Press Release

Exhibit 99.1
N E W S R E L E A S E                                
Contact:
Investor Relations Inquiries
 
Edmund E. Kroll
 
Senior Vice President, Finance & Investor Relations
 
(212) 759-0382
 
Media Inquiries
 
Deanne Lane
 
Vice President, Media Affairs
 
(314) 725-4477

FOR IMMEDIATE RELEASE

CENTENE CORPORATION ANNOUNCES 2015 GUIDANCE AND CONFIRMS 2014 GUIDANCE

ST. LOUIS (December 12, 2014) - Centene Corporation (NYSE: CNC) announced today its 2015 financial guidance. Premium and service revenues are expected to be $20.3 billion to $20.8 billion, representing growth of approximately 32% compared to the 2014 guidance range. Earnings per diluted share are expected to be $5.05 to $5.35, representing an increase of 17% compared to the 2014 guidance range of $4.35 to $4.50.
For its 2015 fiscal year, the Company expects the following results from continuing operations:
Premium and service revenues in the range of $20.3 billion to $20.8 billion.
Earnings per diluted share of approximately $5.05 to $5.35.
Consolidated Health Benefits Ratio of approximately 89.2% to 89.6%.
Consolidated G&A expense ratio in the range of 8.0% to 8.4%.
Effective tax rate of approximately 48.0% to 50.0%.
Diluted shares outstanding of approximately 61.5 million to 62.0 million.
The Company affirms its 2014 revenue guidance in the previously announced range for premium and service revenues of $15.3 billion to $15.8 billion and earnings per diluted share of $4.35 to $4.50. Full year 2014 earnings will be reported on February 3, 2015, at 6:00 AM, with a conference call at 8:30 AM (Eastern Time).
Centene Corporation will host an investor meeting today, including a question-and-answer session, to discuss the details of its guidance. The meeting will begin promptly at 8:30 AM (Eastern Time) and end at approximately 11:45 AM (Eastern Time). Michael F. Neidorff, Chairman and Chief Executive Officer, and William N. Scheffel, Executive Vice President, Chief Financial Officer and Treasurer, of Centene Corporation will host the meeting before an audience of investors at the St. Regis Hotel on East 55th Street, in New York City.
Investors and other interested parties who are unable to attend in person are invited to listen to the investor meeting via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.
About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long Term Care (LTC), in addition to other state-sponsored/hybrid programs, and Medicare (Special Needs Plans). The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, care management software,



correctional systems healthcare, in-home healthcare, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene. Subsequent events and developments may cause the Company's estimates to change. The Company disclaims any obligation to update this forward-looking financial information in the future. Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, competition, membership and revenue projections, timing of regulatory contract approval, changes in healthcare practices, changes in federal or state laws or regulations, changes in expected contract start dates, inflation, provider and state contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare, as well as those factors disclosed in the Company's publicly filed documents. The expiration, cancellation or suspension of Centene's Medicaid Managed Care contracts, or the loss of any appeal of or protest to any such expiration, cancellation or suspension, by state governments would also negatively affect Centene.

###


GRAPHIC 3 logo1.gif GRAPHIC begin 644 logo1.gif M1TE&.#EA]P`]`/<``````(````"``("`````@(``@`"`@+^_P,#RE!;C$T:S$Q=3`Z8C([S(]@"]`;3`_?CD\>SDYA#M%7#E# M9S5&=3E#@#I(:SM*@CE*C#M2ACQD-)A$)09D%/=$)1 MA4%65M MC&1JEF)JFV%OH6-VE6%SGV=UHVIG;VMGFVMK:VILE&IPG6YXJ&R+I7-S7EYJ[-O6W=[>WMSY^CG[.KL M].KO\^SJ\^[N\._Q]>_W__7R^/?O__CX^/K\_/[^_O_[\)^?GWU]??\```#_ M`/__````__\`_P#______R'Y!```````+`````#W`#T`AP```(````"``("` M````@(``@`"`@+^_P,#RE!;C$T:S$Q=3`Z8C([S(]@"]`;3`_?CD\>SDYA#M%7#E#9S5&=3E#@#I(:SM*@CE*C#M2ACQD-)A$)09D%/=$)1A4%65MC&1JEF)JFV%OH6-VE6%SGV=UHVIG;VMG MFVMK:VILE&IPG6YXJ&R+I7-S7EYJ[-O6 MW=[>WMSY^CG[.KL].KO\^SJ\^[N\._Q]>_W__7R^/?O__CX M^/K\_/[^_O_[\)^?GWU]??\```#_`/__````__\`_P#______PC^`.L)'$BP MH,&#"!,J7,BPH<.'$"-*G$BQHL6"[Z"]HE6K%D>.M6"9>W>QI,F3*%.J7#E1 MW9D)(&*XB+$"!`P7*%:X*`&"TS:$Q%"]4N7*E:JA15D-)T>4 MJ-&EK^8E=.?T5=.K5H]:5:KJ:5E73/EP8<&/$C1,/?.=.,DM4/QY\`.&A!8H/+CJS`.U! MQ`,9B7X6#*.@0H,($Q94>`";`84'#B;8QEW!]@0'$E#0&^?`-6S9M"78<8

#&`7?QU[]O';M6\7W[U=NG$&E]C^+#AN7;=V\]"],W#PHUZ?(4F0&(EO M!`F1(H3:(204)#[]^$$X4X\B0]1'!'WV(7B@?$D<\1\2`0JD3BY[H**&."S5 MH\H#,[`P`PTH],#""B"*2&*(+*!P0@?$%%3'!")^B**,)I8X8@\H=+C"##_0 M8\Z.'MKX(0,M'B3.#"NL@".-0$$I4C2`9-0C@BBCDM. MB8(4]:3Q``HH;-D!FEL^T`Q"5W"X9IHS=/``,_74<2:='7B09IH>U,FFH"A8 M4.>=4\5YQ2%$W/#-2J-$`$()+;!PPDZ57HJ""I;BQ.D)'W0`#$%J>$!IIZ=J M^JFGG6X*P@C^.]"##J:H9@J"$-H868(*()S@F0JT`ILJK:JV^NFOM#IP2AT? MU&KLLZIBVH$2]831[*7#?I8%0F"8BBRE$TBCS0BK;@JMIYANBND$QM23RR9A M9(%'!C808ME%\[CR@`01CA=.U+%$-ZR0=-(U#X#`@DPT M;3W3"EN3V"%--"!)TP2.)%9'R%US#3;98XN]0M:8_?;^UUN#@`(N M!OVXX]Q[M\VW3%6&73;AB]/]]02N[%%"X6^+K;C>'L[D@1/UE#&YUVV?:$$X M!H7!=N$33$.-!Z&7?3GAF1L>PP3'U+/'-V0@40(G]81BM4EL:":P9]<2SUFE MH/G*@@DXB<#"`J8(-(<&Q%M*O`N^?H8]\CA5:H(*-]!S3F>?65^^KQW(\+M` MY+0``O,H.#\PSM5GGSSW*'C?O,X?8+G'!L73GO+NM[S]S8]S90"@^0CX`0\< MHG0X!#$79!C18X81`]H\@U5K`E$-F` M2BBP@04"Q:8=24E)4JH9AN8P@1?*R`;^7NK`"28P`0_LBXA&]``1.<`"']GP MASEQH<#2L+XCK2"&4L(B%$\$Q!/IR()K'&CJ`C7D08@$) M,PD]",$`=`UK!#D8A3G$P8HCK!%EZ&*`*^I1JF&E"@A_P$,=_J"'5.*!E7^H M`Q[@@`A9$>N6NV)!!J)!$''L:B>6[)<$>E.!W[BF`KUB5;%&,!L)Z&8V"O`$ M(5Z&K4SMY`>O;"4>LED'6:8R#;P+`S5O:2X4>(`&ZR!(MTI@R:5=PQH9L*:Y M-.5,!C3SF0_^J&=OBC2/4*#"%)GH1@HG,@\+`(UD`KL5-PBB#EIX0`5(VLJ" MK[K5=2/@G4`$UZ&NUI6%>CW(&CR`UK_2H`.62,@6/E?8'DQ@$A!9[%W[:KD> M>(`(ZAA(&";GUZ^FSAH32%QA8W"#]66U(:Z8WP(]D(:!JJ%9\)/^WTYZ\0CJ MG8]X'K##1LD7P,W8#WL4J`7[W#[N]T6QO`F#0;`1O2T$+8I"!H6D!5D_[$%IH,44O7,$$*)$0;2AQ MC?M2H@H8P(E)]!"0\?5`'C::(QC&=X\K>.$)G)#9<"#IO3%\`"$2(@<_=?&% M0'Q`)1*RA@UP,2>#]$!@&Z(&MB)XD!?&8@ER5:W_=@B-?O23#2^<1].R5R&S M<,%-U+7C'CP*(>:00A:RX(4M>"$,6^B"%7)A"`_ M`Y730`8\,*<>'&4GE%V0(AUK+64QD,#^+<#LJAT#"P85R.Y!X#!>3J5L4QZ( M*T+$.>8RE^`'5L9R&K0L:"WCP6I>&.>3[VQG3TV`BCYS,KIN,H%W9H#,C$Y1 M3*+QC4Y[^M.=SNR-99%>I5F@!P-MR,(PUC`0/*`"%I#`!1Y`@5C/6E*BYBBK M+\J_%5Q#'2@M-6GBG)`TU-F##9PP0K(@5*-]P`(.F'6M'W!K"Q2-'0()JD>= MRFT&6*,>2"4?R9;:U(C-[W@H1;<'0,"`7MRX'K2@;%WKBH(?V/@A:_OKO,_* M@K-6]HI"$/5<.]MOK_:[K_V>P![4(4A]BZ@#>A8L80]NV`X\$"&2W3?"_%T_&]J-4W8&=>L!"'8$@J[N:`*^>+=#.ZBI M#P#AW@Z9'L^M2W2=N4\&N>;M`JN;P=&`(`WNBVVGD*MG%;=:T*Y/S&[HTO?,U)!*`W M9`X/T#L6$SQX#._=A[D>_-Z3Q*&<&#[!'-K[BVT@X6);.(R!U#"'/;SXQQL> MBT#,R0W$K@;.%WY3C@]D#/^,X+U+(,:IC^_G9Y^3%'G@[NR=!0MN0A,=XT0( M?F>(RQ;M^S+#`&QH!AOO/7"#7!<_93L6@BK\FOPRTV0%O-<)##S^(&>#T)EO MR<]S0O@,?4R#GV_9W\D.Q$[^YX,@%#_P&_IQHOVO^;[2UAB!^;M6_?2G/P/N M-FK(EEX6X`.IQA`+(QH#\S"O9FL3`&NR-@$1L`+.IX#=`P(RT#04P#_(-H`> M@%W%QG;(Y@'*=A#,9G0(-+(PU,930I MD(+7LX+MIG,T,&]6@B,W8`X),0_B(`[FT(1.:`[AX`YK180BT@,T<"M/X`57 M$`5AX`17L(5A$`57$`8"]R15B`(W$`_=4'LQ,H1M2(1#V`'=5Q"+](8Q8G&* MA0(W$B16PDJ:5,CC:'!$$.FS%W/24*CR""V:,"N;51]K-`.I!9 MA!`!W55-SG)<'(,0RZ4\PH)UT740T\4KK8@]'W`%'`$+'I&,'4$+&Q$/`C&, MY@,L&3`,]6`,%C`"UI0MY5)!U(!!P%*,E*(*S.@1(=&,KS!2-T8,'B!X+Z0" M(+#\60F.:.*/!Z M?P0R[ZB0-G#^@.\V$/-@$_;W9#,@?@:!#3NA?%\S-Q,0"I(@:;%#9B.P!QM5 M?#/P-2$B:K_P`(VYS?^\T`F#CE7%I5J(VDPKQ#C7H7:+!/`P0"?0P$.P0#"KP`>5S M@RD0#(7@`:(!&LZE`7J0E(MY@4@G$.\`!80Y09@9&B`(D2+(6R28$">(BB[P M`)$`5+!E0!5PE@+1#4-0`1[(/9U!;K)5F)5R#G:Y$/3085%B(CAR`FMP"S`'.9@A@7^1@-UZ0MG M8HE-$B55"9&/R(=W>'$'<8A[:(G-29W2Z0[N.9W1>9WUD`6(V(99J9H"40L/ M4"5MB")0LE21EXA5TB'!=YOU8`V34B[E(@$6<`(5\#&XE"D>``CUL':>PG3` M@@(Y<`,VH`,ST*$?2@,=&J)((#[%TG.S2).9X)JX^**CN8L'44HC0RM9)UT; M<"SJHCP?&J(>J@,D>@,S`*0ML"W26(P9H`P$,0^3$$'"([;HRZ44@LK MY0LV-556%0R]L%[L108-8#2-%C0JE,V91F5 M6(D"1>(RC,!^LE>M<``)E5` M\>.#Y!4!0`"-]9"`^#.;\E,_U3-1MA29^8.!=;E7Q&6#/[B9!V%L'>29)5@Z MI]FNJJ5TO]49'<`$-\.N\I.:!V$%YY5>>IF#\#2;F+E`PI9>3#.3H[`G8$)( M,+0D7_(`/R#^CWGB)R<;LR62LD'4!!;S)5,R2-QI$*Z0G(`DGJ0X$&GPB"F; M(PX$FB>0LRFBLB%"LU#2`9P3!DF+0R^6K0:!#DU@8@#Z)0(JLTW+)4_"M>UB MEZH@!*;"H)/R+;92`GCP8])S;*HR*>V4BR`P!"@JBN:4IP61!A-@2M;TIY9W M*K_X7(F@=93*:,$RH707J8@:+1E0)`;!"A)P+BNI.N"8ME2ZC?+4C:EJE^5@ M!1T@*063,4HE`3:@"Z73&K111"*C-)S!4^!3IRWP,5EYIWI+$/3(:C(#N!!I M42P`,G":45]F$&7P`/`H;J3K,*_+:A^`0,:;ET+\`G(TZ("O9:%`=T+\3$`/R.Q`O,L#_&\`E\)#(2E=E MI01?8`6?\`F\4`X&X04/T`'_N[_N*\$E+,`F_`!W@+H(2A#H@`W+``4,@@3T,0QW]!#; M<`W:@`U43,56K`W7@`U:K,5[+*!RG8@ M4`5W4`5,``5?H`F:P,&6T0UD7,99C,7^5[S&:SQ2?$S&7:S&PWL0X3#&:RR= M@'S(@=S%UZ`&66`#]!$%0C`,SQ`+L>"E1UP/CA'*?_G),\FW,"D&:-`$:#(! M9%`-GX#'!T#*[^8.R:`)W.`8]2`,BZ`)B^#!LOS+I!R1)9`#D$`%&"!F'*`( M]9`,B[`(]P#,IU4.S;Q0`Z'+>=S`T)S-6;4P,[`(59`S67<`@<`+,JG-%%$- MBX`/_PH.^/`)X&#.\'Q:>C(&?M`!^R9?/\4-O!#/*N$.^.#,_!S0[Q8&/H`) M--!;GWD0^GP/#-W!2WH/O,#0X/`,#)T,RQS1PC`/!Q#1O/`,*00.$=W0OES- M%3T/%'T/&5W^#R;-T"Q]#XF<#*^\P;S0R`!8S0D(.7T`3A#KSP"CP M#&0MU18M(<+`UJ]_=7#BP[_'`L#H0ZXW=G)@%7H8-K$ M70_O70^6_=5U"0YX'-CU4`XQ3)/-^+H.#U M8-R:D-("P0U0_/-_H_=#IG!CE@,?4S%`+C@[JH-K#/1`GGN-&#M4*?MN+P.($ M$0MYO%X'D-L%\>$A#LS/<-D-4"&[W,"PO0B=/1`R[L&U;,L& MP/F6B'67$W5*OW4@>#H MO)`->>WD]0`.4%T-!?'6Y*S2>;W7!L$-N^S+68X/EN'JV[WHLIS6(S-\/YN MT:[<,AGQ]X+^#AJO[=AN$.CLS@5Q`*\5>WQXF!U1C_Y'$N$%D>Z).^R^#NZY]0E^KMZ"UOUE[*[DOJ]-W.RX*^WN6\ M]"SA[DU>#NOL]NAPV5^F#EF^"!Y]]>DLOZ)NZ_C=]9H`ZRV.]J*F#EQ^#XEA MW`8OYJ.NTB.^P>JP7BY.XH7.'%L?G?40^O>P7J+>Y-6Y`=0#V3']#+]O^^]>ZLT<"[G?U3#^WO0.SE!O M_?\`P_WO4^+!N)+IA!< MH$6QYBFL=P#?(H<5P1T(I"D0OG+UY@GC*/#316X4'-5I+H M5&[9<")TE_5B3ZQ1ZZES:E8AU*=KP94]6X^NUI[@^&),RVWK4L*%#1]&G#CI MST^#%3^&'%GR9,J5*?,*:EGS9LZ=/7\:QHB9)VC2I4V?/LWMDR9>J%V_AAU; ']NS'`0$`.S\_ ` end